Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · IEX Real-Time Price · USD
0.700
-0.063 (-8.29%)
May 2, 2024, 3:55 PM EDT - Market closed
CCM Revenue
In the year 2023, Concord Medical Services Holdings had annual revenue of $75.80M with 11.91% growth.
Revenue (ttm)
$75.80M
Revenue Growth
-0.11%
P/S Ratio
0.45
Revenue / Employee
$104,260
Employees
727
Market Cap
33.84M USD
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 75.80M | 8.07M | 11.91% |
Dec 31, 2022 | 67.73M | -8.15M | -10.74% |
Dec 31, 2021 | 75.88M | 41.78M | 122.53% |
Dec 31, 2020 | 34.10M | 5.76M | 20.33% |
Dec 31, 2019 | 28.34M | 711.23K | 2.57% |
Dec 31, 2018 | 27.63M | -22.40M | -44.78% |
Dec 31, 2017 | 50.03M | -15.92M | -24.14% |
Dec 31, 2016 | 65.95M | -29.02M | -30.56% |
Dec 31, 2015 | 94.97M | -3.01M | -3.07% |
Dec 31, 2014 | 97.98M | 5.14M | 5.54% |
Dec 31, 2013 | 92.84M | 19.77M | 27.05% |
Dec 31, 2012 | 73.07M | 1.67M | 2.34% |
Dec 31, 2011 | 71.40M | 12.39M | 20.99% |
Dec 31, 2010 | 59.01M | 16.18M | 37.78% |
Dec 31, 2009 | 42.83M | 17.66M | 70.14% |
Dec 31, 2008 | 25.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortress Biotech | 84.51M |
Retractable Technologies | 43.60M |
CASI Pharmaceuticals | 33.88M |
Precision Optics Corporation | 19.22M |
ImmunoPrecise Antibodies | 17.67M |
CCM News
- 13 days ago - Concord Medical Files 2023 Annual Report on Form 20-F - PRNewsWire
- 5 weeks ago - Canagold Resources Ltd. Announces Closing of $4.1M Charity Flow Through Financing - Business Wire
- 2 months ago - Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price - PRNewsWire
- 4 months ago - Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited - PRNewsWire
- 4 months ago - Canagold Appoints Chris Pharness as Senior Vice President Sustainability and Permitting - Business Wire
- 5 months ago - Concord Medical Schedules 2023 Annual Meeting of Shareholders - PRNewsWire
- 7 months ago - Concord Medical Reports Financial Results for the First Half of 2023 - PRNewsWire
- 10 months ago - Canagold Files NI 43-101 Technical Report for New Polaris Mineral Resource Estimate - Business Wire